1. Home
  2. GRFS vs BFAM Comparison

GRFS vs BFAM Comparison

Compare GRFS & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • BFAM
  • Stock Information
  • Founded
  • GRFS 1940
  • BFAM 1986
  • Country
  • GRFS Spain
  • BFAM United States
  • Employees
  • GRFS N/A
  • BFAM N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • BFAM Other Consumer Services
  • Sector
  • GRFS Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • GRFS 6.6B
  • BFAM 5.7B
  • IPO Year
  • GRFS 2006
  • BFAM 1997
  • Fundamental
  • Price
  • GRFS $9.11
  • BFAM $103.03
  • Analyst Decision
  • GRFS Hold
  • BFAM Buy
  • Analyst Count
  • GRFS 1
  • BFAM 7
  • Target Price
  • GRFS $10.30
  • BFAM $132.43
  • AVG Volume (30 Days)
  • GRFS 592.2K
  • BFAM 935.2K
  • Earning Date
  • GRFS 01-01-0001
  • BFAM 10-30-2025
  • Dividend Yield
  • GRFS 1.58%
  • BFAM N/A
  • EPS Growth
  • GRFS 132.60
  • BFAM 72.80
  • EPS
  • GRFS 0.53
  • BFAM 3.47
  • Revenue
  • GRFS $8,744,226,659.00
  • BFAM $2,874,055,000.00
  • Revenue This Year
  • GRFS $5.46
  • BFAM $10.42
  • Revenue Next Year
  • GRFS $6.69
  • BFAM $7.11
  • P/E Ratio
  • GRFS $22.60
  • BFAM $29.61
  • Revenue Growth
  • GRFS 9.32
  • BFAM 9.38
  • 52 Week Low
  • GRFS $6.19
  • BFAM $91.49
  • 52 Week High
  • GRFS $11.14
  • BFAM $135.78
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 36.85
  • BFAM 50.85
  • Support Level
  • GRFS $9.14
  • BFAM $91.49
  • Resistance Level
  • GRFS $9.50
  • BFAM $109.86
  • Average True Range (ATR)
  • GRFS 0.29
  • BFAM 3.28
  • MACD
  • GRFS -0.02
  • BFAM 0.98
  • Stochastic Oscillator
  • GRFS 26.39
  • BFAM 63.12

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: